Elan completes $101.8m sale

Elan Pharmaceutical has completed the sale of its four pain products and related assets to aaiPharma Inc for $101.8m.(€83.6m).

Elan completes $101.8m sale
Tue, 02 Dec, 2003 - 17:15

Elan Pharmaceutical has completed the sale of its four pain products and related assets to aaiPharma Inc for $101.8m.(€83.6m).

This includes the rights to its Roxicodone, Roxanol and Duraclon products.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €10/month. Ts&Cs apply.

More in this section

empty J1 USA visa for man US visa crackdown is an assault on students' rights
Sad boy standing alone in the hallway Derval McDonagh: We cannot say what happened to Grace will not happen again 
AI chat technology, Businessman use smartphone with virtual screen of AI chatbot communicate and answer questions. Artificial in Agentic opportunity for Irish business: The time to act is now
CourtsBusinessHeathrowPlace: New YorkPlace: LondonPlace: DublinOrganisation: ElanOrganisation: Elan PharmaceuticalOrganisation: aaiPharma Inc
<p>In the first eight months of the year, 116,099 new cars were registered, a 3.4% increase, of which 20,656 were electric cars representing a 37% year-on-year increase. File picture</p>

Electric car sales surge by 70% in Ireland, but Tesla's decline continues

READ NOW

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Latest

Business

Push Notifications

By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.

Sign Up
IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Fergus Finlay
Fergus Finlay

Analysis

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited